IFP Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$81.5K Sell
200
-32
-14% -$13K ﹤0.01% 1764
2025
Q1
$62.6K Sell
232
-9
-4% -$2.43K ﹤0.01% 1781
2024
Q4
$56.7K Buy
241
+47
+24% +$11.1K ﹤0.01% 1774
2024
Q3
$53.6K Buy
194
+145
+296% +$40K ﹤0.01% 1702
2024
Q2
$11.9K Sell
49
-421
-90% -$102K ﹤0.01% 2284
2024
Q1
$70.2K Buy
470
+14
+3% +$2.09K ﹤0.01% 1449
2023
Q4
$87.2K Buy
456
+2
+0.4% +$382 ﹤0.01% 1305
2023
Q3
$80.3K Buy
454
+1
+0.2% +$177 ﹤0.01% 1361
2023
Q2
$86K Sell
453
-3
-0.7% -$570 ﹤0.01% 1381
2023
Q1
$45.9K Sell
456
-203
-31% -$20.4K ﹤0.01% 1623
2022
Q4
$80K Sell
659
-224
-25% -$27.2K ﹤0.01% 1890
2022
Q3
$109K Buy
883
+143
+19% +$17.7K ﹤0.01% 1793
2022
Q2
$93K Hold
740
﹤0.01% 1727
2022
Q1
$93K Buy
740
+363
+96% +$45.6K ﹤0.01% 1727
2021
Q4
$73K Buy
377
+7
+2% +$1.36K ﹤0.01% 1378
2021
Q3
$77K Buy
370
+15
+4% +$3.12K ﹤0.01% 1360
2021
Q2
$60K Buy
355
+320
+914% +$54.1K ﹤0.01% 1446
2021
Q1
$5K Buy
35
+23
+192% +$3.29K ﹤0.01% 2370
2020
Q4
$1K Sell
12
-1
-8% -$83 ﹤0.01% 2693
2020
Q3
$1K Buy
13
+4
+44% +$308 ﹤0.01% 2565
2020
Q2
$1K Hold
9
﹤0.01% 2466
2020
Q1
$1K Hold
9
﹤0.01% 2434
2019
Q4
$1K Hold
9
﹤0.01% 2609
2019
Q3
$1K Buy
+9
New +$1K ﹤0.01% 2804
2019
Q1
Sell
-200
Closed -$14K 2374
2018
Q4
$14K Sell
200
-361
-64% -$25.3K ﹤0.01% 2287
2018
Q3
$49K Buy
561
+100
+22% +$8.73K ﹤0.01% 1895
2018
Q2
$45K Buy
+461
New +$45K ﹤0.01% 1956
2017
Q4
Sell
-107
Closed -$13K 3737
2017
Q3
$13K Buy
+107
New +$13K ﹤0.01% 2827
2016
Q3
Sell
-220
Closed -$12K 3868
2016
Q2
$12K Buy
+220
New +$12K ﹤0.01% 2632
2016
Q1
Sell
-278
Closed -$26K 2380
2015
Q4
$26K Buy
+278
New +$26K ﹤0.01% 1991